Bahamas vs Europe (WHO region): Previously treated cases tested for RR-/MDR-TB
Bahamas
100.0%
in 2020
Europe (WHO region)
90.0%
in 2024
Bahamas rank
1st
Europe (WHO region) rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Bahamas
- Europe (WHO region)
How they compare
Bahamas currently reports 100.0% against 90.0% in Europe (WHO region), a difference of 10.0%.
That makes Bahamas's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 4 times across 12 shared years of data; in 2007 it was Bahamas ahead.
Bahamas ranks 1st and Europe (WHO region) ranks 2nd of 180 countries.
Bahamas has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahamas | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.0% | 24.3% | 49.7% | Bahamas |
| 2010s | 58.4% | 55.0% | 3.4% | Bahamas |
| 2020s | 100.0% | 94.0% | 6.0% | Bahamas |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bahamas or Europe (WHO region)?
- Bahamas, at 100.0% against 90.0% in Europe (WHO region) as of 2020.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bahamas and Europe (WHO region)?
- 10.0%, with Bahamas ahead.
- How many years of comparable data are there for Bahamas and Europe (WHO region)?
- 12 years are reported by both, from 2007 to 2020.
- How do Bahamas and Europe (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Bahamas ranks 1st and Europe (WHO region) ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.